Literature DB >> 2549648

The endorectal ileal pullthrough procedure in patients with ulcerative colitis and familial polyposis with carcinoma.

M Stelzner1, E W Fonkalsrud.   

Abstract

Since 1977, 196 patients (177 with ulcerative colitis and 19 with familial polyposis) have undergone colectomy, mucosal proctectomy and endorectal ileal pull-through with or without an ileal reservoir (PTR) at UCLA Medical Center. Fourteen of the patients (7.1 per cent) had carcinoma of the colon or rectum at the time of operation; 12 had colitis and two, polyposis. Another 40 patients had mucosal dysplasia. Only five of the 14 patients with carcinoma were diagnosed before operation despite close surveillance by gastroenterologists. The mean duration of colitis before the diagnosis of carcinoma was made was 17 years; the mean age that the carcinoma was identified was 38 years. Eleven of the 12 patients with colitis had universal involvement. Two patients with colitis and carcinoma who underwent colectomy and PTR died a mean of 30.5 months postoperatively of metastatic disease. Twelve patients with carcinoma (ten with colitis and two with polyposis) are alive a mean of 29 months postcolectomy and PTR; two of these have received chemotherapy. The low mortality (0.4 per cent) and good clinical results after colectomy and the PTR procedure and the unexpectedly high incidence of carcinoma and mucosal dysplasia among patients referred for operation suggest that surgical treatment should be considered at an earlier stage than the current general practice, particularly in patients at high risk (mucosal dysplasia, pancolitis and duration of more than ten years).

Entities:  

Mesh:

Year:  1989        PMID: 2549648

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Proctocolectomy for colorectal cancer--is the ileal pouch anal anastomosis a safe alternative to permanent ileostomy?

Authors:  Ryan Snelgrove; Carl J Brown; Brenda I O'Connor; Harden Huang; J Charles Victor; Robert Gryfe; Helen MacRae; Zane Cohen; Robin S McLeod
Journal:  Int J Colorectal Dis       Date:  2014-10-17       Impact factor: 2.571

2.  Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect.

Authors:  W H de Vos tot Nederveen Cappel; E Buskens; P van Duijvendijk; A Cats; F H Menko; G Griffioen; J F Slors; F M Nagengast; J H Kleibeuker; H F A Vasen
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

3.  Ulcerative colitis and coexisting colorectal cancer: recurrence rate after restorative proctocolectomy.

Authors:  Y Ziv; V W Fazio; S A Strong; J R Oakley; J W Milsom; I C Lavery
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

4.  The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

Authors:  G Winde; H G Gumbinger; H Osswald; F Kemper; H Bünte
Journal:  Int J Colorectal Dis       Date:  1993-03       Impact factor: 2.571

5.  An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer.

Authors:  Scott D Ramsey; Wylie Burke; Lauren Clarke
Journal:  Genet Med       Date:  2003 Sep-Oct       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.